Institute of Clinical Medicine is participating in CHROMED (Clinical tRials fOr elderly patients with MultiplE Disease) project
Institute of Clinical Medicine is participating in CHROMED (Clinical tRials fOr elderly patients with MultiplE Disease) project.
CHROMED is an European project aimed at evaluating the impact of adopting a health and lifestyle status management system to support elderly patients with a combination of chronic diseases involving respiratory and cardiovascular systems. A large scale clinical trial will be implemented to develop and evaluate clinical protocols and organizational models based on the new technologies in order to improve both quality of life and healthcare costs associated with these patients. The CHROMED project focuses its investigation on the applicability of an integrated solution for a pathological condition which: a) is very prevalent in ageing patients and b) severely impairs quality of life: COPD with other typical comorbidities such as congestive heart failure and sleep disordered breathing. For over 9 months, an international multi-centric randomized control trial will be implemented on 300 patients in five European regions: United Kingdom, Sweden, Estonia, Spain and Slovenia, representing different social and organizational contexts in Europe. In each country, the participating care organizations have existing practices and procedures for age-related disease management. In CHROMED a specific ICT platform in combination with a set of both well established and innovative devices will be used to collect and process useful clinical data at the patient’s home. In particular, for each patient a set of devices will be defined considering the existing co-morbidities.
The study is addressed to benefit several target groups:
Elderly: they can take advantages from CHROMED in terms of personalized care assistance, improvement of communication with doctors, continuous health status monitoring and check of behaviour, improvement of quality of life, support in taking decisions related to lifestyle, improvement of patient adherence to therapies.
Clinicians: can substantially prolong the time that elderly people can live at home by providing ICT-based safety, improve communication with patients, reduce unnecessary visits to hospitals, promote exacerbations prevention by patient training to a more healthy lifestyle, deliver evidence of improvements for quality of life of older people and their families.
Enterprises, in terms of: large scale validation, know-how development, improvement of the devices according to the users experience and international standards, promotion of their products in the market at European level in glance of the project results evidence, creation of new business opportunities, approval of new patents.
Academics, through: formalization of new guidelines in the telemedicine applications for clinicians and health managers concerning the impact of COPD and CHF in ageing at the European level, generation of new data for newer studies, international cooperation in the research fields of the project.
Public health authorities, which can find new methodologies in the treatment of exacerbations outside of the hospital with a consequent reduction of costs for hospital readmission and visits and improve in efficacy of treatment regimens.
The added values of CHROMED solution are:
Clinical-medical: early and in-time detection of disease worsening conditions;
Economical: in-time predicted worsening of chronic disorders can diminishes the need of hospitalization and out-patient visits economizing burden of total medical costs
Social: the best prevention of worsening the chronic disorders and prevention of well-being within elderly habitants is accurate monitoring of these patients’ health condition; prevention of chronic disease has enormous impact to society costs and wellbeing especially in elderly habitants.